IL-15 up-regulates the MMP-9 expression levels and induces inflammatory infiltration of macrophages in polymyositis through regulating the NF-kB pathway

Gene

Volumn 592, Issue 1, 2016, Pages 137-147

  Yan, Wang ^a   Fan, Weinv ^a   Chen, Caijing ^a   Wu, Yunqin ^a   Fan, Zhenyi ^a   Chen, Jiaqi ^a   Chen, Zhaoying ^a   Chen, Huimin ^a  

^a NINGBO NO 2 HOSPITAL   (China)

Author keywords

ERK; IKB; IL 15; Inflammatory infiltration; Macrophage; MMP 9; NF kB; Polymyositis

Indexed keywords

CD163 ANTIGEN; CREATINE KINASE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3; HORMONE; I KAPPA B KINASE ALPHA; INTERLEUKIN 15 RECEPTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MIDDLE AGED; NONHUMAN; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; INFLAMMATION; METABOLISM; MUSCLE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-15; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUSCLES; NF-KAPPA B; NF-KAPPAB INHIBITOR ALPHA; PHOSPHORYLATION; POLYMYOSITIS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-15; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84989967028     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.06.055     Document Type: Article

References (79)

1. Anguille, S., Van Acker, H.H., Van den Bergh, J., Willemen, Y., Goossens, H., Van Tendeloo, V.F., et al. Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner. PLoS One, 10, 2015, e0123340.
2. Anguille, S., et al. Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner., 10, 2015, e0123340.
3. Carbo, N., Lopez-Soriano, J., Costelli, P., Busquets, S., Alvarez, B., Baccino, F.M., et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br. J. Cancer 83 (2000), 526–531.
4. Carbo, N., et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats., 83, 2000, 526–531.
5. Choi, Y.C., Dalakas, M.C., Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies., 54, 2000, 65–71.
6. Choi, Y.C., Dalakas, M.C., Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54 (2000), 65–71.
7. Constantinescu, C.S., Grygar, C., Kappos, L., Leppert, D., Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells., 13, 2001, 244–247.
8. Constantinescu, C.S., Grygar, C., Kappos, L., Leppert, D., Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells. Cytokine 13 (2001), 244–247.
9. Dorph, C., Englund, P., Nennesmo, I., Lundberg, I.E., Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann. Rheum. Dis. 65 (2006), 1565–1571.
10. Doyle, S.L., Shirey, K.A., McGettrick, A.F., Kenny, E.F., Carpenter, S., Caffrey, B.E., et al. Nuclear factor kappaB2 p52 protein has a role in antiviral immunity through IkappaB kinase epsilon-dependent induction of Sp1 protein and interleukin 15. J. Biol. Chem. 288 (2013), 25066–25075.
11. Doyle, S.L., et al. Nuclear factor kappaB2 p52 protein has a role in antiviral immunity through IkappaB kinase epsilon-dependent induction of Sp1 protein and interleukin., 15.288, 2013, 25066–25075.
12. Engel, A.G., Arahata, K., Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis., 16, 1984, 209–215.
13. Engel, A.G., Arahata, K., Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16 (1984), 209–215.
14. Ernestam, S., af Klint, E., Catrina, A.I., Sundberg, E., Engstrom, M., Klareskog, L., et al. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor. Arthritis Res. Ther., 8, 2006, R18.
15. Ernestam, S., et al. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor., 8, 2006, R18.
16. Fu, Y., Quan, R., Zhang, H., Hou, J., Tang, J., Feng, W.H., Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-kappaB signaling pathway., 86, 2012, 7625–7636.
17. Fu, Y., Quan, R., Zhang, H., Hou, J., Tang, J., Feng, W.H., Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-kappaB signaling pathway. J. Virol. 86 (2012), 7625–7636.
18. Fukushima, K., Nakamura, A., Ueda, H., Yuasa, K., Yoshida, K., Takeda, S., et al. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). BMC Musculoskelet. Disord., 8, 2007, 54.
19. Fukushima, K., et al. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ)., 8, 2007, 54.
20. Furmanczyk, P.S., Quinn, L.S., Interleukin-15 increases myosin accretion in human skeletal myogenic cultures., 27, 2003, 845–851.
21. Furmanczyk, P.S., Quinn, L.S., Interleukin-15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol. Int. 27 (2003), 845–851.
22. Gillgrass, A., Gill, N., Babian, A., Ashkar, A.A., The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages., 193, 2014, 6184–6191.
23. Gillgrass, A., Gill, N., Babian, A., Ashkar, A.A., The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages. J. Immunol. 193 (2014), 6184–6191.
24. Greenberg, S.A., Pinkus, J.L., Pinkus, G.S., Burleson, T., Sanoudou, D., Tawil, R., et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57 (2005), 664–678.
25. Greenberg, S.A., et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis., 57, 2005, 664–678.
26. Grundtman, C., Salomonsson, S., Dorph, C., Bruton, J., Andersson, U., Lundberg, I.E., Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies., 56, 2007, 674–687.
27. Grundtman, C., Salomonsson, S., Dorph, C., Bruton, J., Andersson, U., Lundberg, I.E., Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum. 56 (2007), 674–687.
28. Han, L.N., Li, T.L., Ding, G.L., Liu, J.W., Ding, Y., Zhang, Y.J., Establishment of human cardiac C protein induced experimental autoimmune myocarditis model in rat., 40, 2012, 690–696.
29. Han, L.N., Li, T.L., Ding, G.L., Liu, J.W., Ding, Y., Zhang, Y.J., Establishment of human cardiac C protein induced experimental autoimmune myocarditis model in rat. Zhonghua Xin Xue Guan Bing Za Zhi 40 (2012), 690–696.
30. Henriksson, K.G., “Semi-open” muscle biopsy technique. A simple outpatient procedure., 59, 1979, 317–323.
31. Henriksson, K.G., “Semi-open” muscle biopsy technique. A simple outpatient procedure. Acta Neurol. Scand. 59 (1979), 317–323.
32. Huang, P.L., Hou, M.S., Wang, S.W., Chang, C.L., Liou, Y.H., Liao, N.S., Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis., 5, 2015, 33.
33. Huang, P.L., Hou, M.S., Wang, S.W., Chang, C.L., Liou, Y.H., Liao, N.S., Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet. Muscle, 5, 2015, 33.
34. Kousios, A., Kouis, P., Panayiotou, A.G., Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review., 2016 (2016a,9498013).
35. Kousios, A., Kouis, P., Panayiotou, A.G., Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int. J. Nephrol. Renov. Dis., 2016, 2016, 9498013.
36. Kruger, N.J., The Bradford method for protein quantitation., 32, 1994, 9–15.
37. Kruger, N.J., The Bradford method for protein quantitation. Methods Mol. Biol. 32 (1994), 9–15.
38. Li, H., Mittal, A., Paul, P.K., Kumar, M., Srivastava, D.S., Tyagi, S.C., et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J. Biol. Chem. 284 (2009), 4439–4450.
39. Li, H., et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy., 284, 2009, 4439–4450.
40. Mattiola, I., Pesant, M., Tentorio, P.F., Molgora, M., Marcenaro, E., Lugli, E., et al. Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1beta, IFN-beta, and IL-15 Pathways. J. Immunol. 195 (2015), 2818–2828.
41. Mattiola, I., et al. Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1beta, IFN-beta, and IL-15 Pathways., 195, 2015, 2818–2828.
42. McInnes, I.B., al-Mughales, J., Field, M., Leung, B.P., Huang, F.P., Dixon, R., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2 (1996), 175–182.
43. McInnes, I.B., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis., 2, 1996, 175–182.
44. McInnes, I.B., Leung, B.P., Sturrock, R.D., Field, M., Liew, F.Y., Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis., 3, 1997, 189–195.
45. McInnes, I.B., Leung, B.P., Sturrock, R.D., Field, M., Liew, F.Y., Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 3 (1997), 189–195.
46. Mielnik, P., Chwalinska-Sadowska, H., Wiesik-Szewczyk, E., Maslinski, W., Olesinska, M., Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity., 32, 2012, 639–643.
47. Mielnik, P., Chwalinska-Sadowska, H., Wiesik-Szewczyk, E., Maslinski, W., Olesinska, M., Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity. Rheumatol. Int. 32 (2012), 639–643.
48. Milisenda, J.C., Selva-O'Callaghan, A., Grau, J.M., The diagnosis and classification of polymyositis., 48-49, 2014, 118–121.
49. Milisenda, J.C., Selva-O'Callaghan, A., Grau, J.M., The diagnosis and classification of polymyositis. J. Autoimmun. 48-49 (2014), 118–121.
50. Mitchell, S., Vargas, J., Hoffmann, A., Signaling via the NFkappaB system., 8, 2016, 227–241.
51. Mitchell, S., Vargas, J., Hoffmann, A., Signaling via the NFkappaB system. Wiley Interdiscip. Rev. Syst. Biol. Med. 8 (2016), 227–241.
52. Notarnicola, A., Lapadula, G., Natuzzi, D., Iannone, F., Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies., 66, 2014, 215–223.
53. Notarnicola, A., Lapadula, G., Natuzzi, D., Iannone, F., Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies. Reumatizam 66 (2014), 215–223.
54. Park, S.L., Kim, W.J., Moon, S.K., p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-kappaB/MMP-9 pathway., 22, 2014, 59–65.
55. Park, S.L., Kim, W.J., Moon, S.K., p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-kappaB/MMP-9 pathway. Int. Immunopharmacol. 22 (2014), 59–65.
56. Peng, Q.L., Zhang, Y.L., Shu, X.M., Yang, H.B., Zhang, L., Chen, F., et al. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. J. Rheumatol. 42 (2015), 979–987.
57. Peng, Q.L., et al. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue., 42, 2015, 979–987.
58. Rodolico, C., Mazzeo, A., Toscano, A., Messina, S., Aguennouz, M., Gaeta, M., et al. Specific matrix metalloproteinase expression in focal myositis: an immunopathological study. Acta Neurol. Scand. 112 (2005), 173–177.
59. Rodolico, C., et al. Specific matrix metalloproteinase expression in focal myositis: an immunopathological study., 112, 2005, 173–177.
60. Ruckert, R., Brandt, K., Ernst, M., Marienfeld, K., Csernok, E., Metzler, C., et al. Interleukin-15 stimulates macrophages to activate CD4 + T cells: a role in the pathogenesis of rheumatoid arthritis?. Immunology 126 (2009), 63–73.
61. Ruckert, R., et al. Interleukin-15 stimulates macrophages to activate CD4 + T cells: a role in the pathogenesis of rheumatoid arthritis?., 126, 2009, 63–73.
62. Schoser, B.G., Blottner, D., Stuerenburg, H.J., Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers., 105, 2002, 309–313.
63. Schoser, B.G., Blottner, D., Stuerenburg, H.J., Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers. Acta Neurol. Scand. 105 (2002), 309–313.
64. Spirig, R., Schaub, A., Kropf, A., Miescher, S., Spycher, M.O., Rieben, R., Reconstituted high-density lipoprotein modulates activation of human leukocytes., 8, 2013, e71235.
65. Spirig, R., Schaub, A., Kropf, A., Miescher, S., Spycher, M.O., Rieben, R., Reconstituted high-density lipoprotein modulates activation of human leukocytes. PLoS One, 8, 2013, e71235.
66. Stone, K.B., Oddis, C.V., Fertig, N., Katsumata, Y., Lucas, M., Vogt, M., et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 56 (2007), 3125–3131.
67. Stone, K.B., et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy., 56, 2007, 3125–3131.
68. Sugiura, T., Harigai, M., Kawaguchi, Y., Takagi, K., Fukasawa, C., Ohsako-Higami, S., et al. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int. Immunol. 14 (2002), 917–924.
69. Sugiura, T., et al. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis., 14, 2002, 917–924.
70. Tateyama, M., Nagano, I., Yoshioka, M., Chida, K., Nakamura, S., Itoyama, Y., Expression of tumor necrosis factor-alpha in muscles of polymyositis., 146, 1997, 45–51.
71. Tateyama, M., Nagano, I., Yoshioka, M., Chida, K., Nakamura, S., Itoyama, Y., Expression of tumor necrosis factor-alpha in muscles of polymyositis. J. Neurol. Sci. 146 (1997), 45–51.
72. Troyanov, Y., Targoff, I.N., Payette, M.P., Raynauld, J.P., Chartier, S., Goulet, J.R., et al. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine 93 (2014), 318–332.
73. Troyanov, Y., et al. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features., 93, 2014, 318–332.
74. Waldmann, T.A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design., 6, 2006, 595–601.
75. Waldmann, T.A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6 (2006), 595–601.
76. Williams, M.T., Yousafzai, Y., Cox, C., Blair, A., Carmody, R., Sai, S., et al. Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood 123 (2014), 3116–3127.
77. Williams, M.T., et al. Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia., 123, 2014, 3116–3127.
78. Zong, M., Loell, I., Lindroos, E., Nader, G.A., Alexanderson, H., Hallengren, C.S., et al. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor alpha expression in muscle tissue of patients with polymyositis or dermatomyositis. Ann. Rheum. Dis. 71 (2012), 1055–1063.
79. Zong, M., et al. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor alpha expression in muscle tissue of patients with polymyositis or dermatomyositis., 71, 2012, 1055–1063.